Thanks so much for the opportunity and hospitality. It was a lot of fun and we were very happy that we generated interest and contacts. Please let me know if there is anything I can do for you in the future. Your work with the 128 Innovation Capital Group really is a great help and support to the entrepreneurial community.
Bill Leak, Whipshotz
Piranha Pond Presenter, June 2013
The Piranaha Pond event at SNEEF has been one of our most successful events to date. It brought a diversity of startups, with founders who were able to get expert advice from a panel of seasoned investors and make connections. Likewise, the audience had the opportunity to learn about these startups and hear from the experts about how they can grow.
Diana Jennings, Chair, Board of Advisors
Southern New England Entrepreneurs Network (SNEEF)
At the Piranha Pond events, only 8 entrepreneurs are selected to present to the investor panel. There are others who have applied whose companies are exciting and innovative and deserving of investment. You can see them here.
The investors who have participated at the Piranha Pond events give generously of their time and counsel. They are primarily Angel Investors or early stage Venture Capitalists. They help our entrepreneurs and our audience understand what they are seeking in a company before writing a check.
Additional Piranha Pond events are scheduled for later this year:
September 11, 2014 at SNEEF
December 11, 2014 in Waltham
Thursday, September 11th from 6:00 - 9:00 PM at
the Southern New England Entrepreneurs Forum
Applications to present at this event accepted starting August 5, 2014.
Application deadline is Monday, September 1, 2014
What is the Piranha Pond? It is a “pitch party” where a select group of entrepreneurs has up to 5 minutes to convince a panel of investors to meet with them to further discuss their ventures. Using a format similar to the popular television show Shark Tank, our investors provide feedback to the entrepreneurs about their presentations and companies, and information to all about why they decide to be “In” or “Out.” If they are “In” they will meet with the Entrepreneur at a later time to discuss their company. If they are “Out” there is no interest at this time. Again, the investor lets us know why s/he will not move forward with the presenter.
For this event, we seek companies beyond the idea stage. The ideal company will have raised funds from friends, family, and/or grants such as SBIR’s. If the company’s product is a software or SAAS product, it should be in beta testing or later.
Please note: There is a $50 application fee required in order to be considered. A selection committee will choose the top 8 applicants to present. The successful applicants will be deemed to have companies most likely to interest the investment panel. In the past, the successful companies have been beyond the idea stage, with a finished product and/or revenue or significant progress toward commercialization if a pharma, equipment or medical device company.
This is a public event.
Attendance fees for this meeting:
General admission - $35
128ICG Members - $25
SNEEF Members - No Charge
Beacon Angels and
Individual Angel Investor
Mass Medical Angels is a seed stage investor group exclusively focused on life science and healthcare investments.
Beacon Angels is a Boston-based angel group that makes investments in the $100,000 to $300,000 range in small fast-growing companies.
MassVentures is a venture capital firm focused on fueling the Massachusetts innovation economy by funding early-stage, high-growth Massachusetts startups as they move from concept to commercialization.
MassVentures focuses on Series A investments and considers occasional and opportunistic seed rounds. We provide capital for first-time CEOs and/or founders and consider industry segments not adequately served by the venture community.
|Dr. Sanders is currently investing in Life Science opportunities primarily medical device, pharma, and diagnostics. He rarely invests in opportunities outside of life sciences unless there is a strategic long term benefit.||Cherrystone invests across a wide array of industries but tends to specialize in the biopharma, medical device, consumer product and technology fields. The most successful companies have a defensible technology/product with initial prototypes and beta customers with early traction. In the case of medical companies, they have a clearly defined FDA path and initial data supporting their claims.|